Podbit · The iGaming Leader
Losing £10 in gambling requires winning back £20 to feel whole — that's textbook loss aversion. Savvas is exploring whether shared, synchronous gaming experiences reduce that multiplier. If it drops from 2x to 1.2x, it changes what gambling feels like entirely.
Where this was said
At 40:55 · chapter starts 38:50
Asked about his vision for MrQ beyond the traditional casino format, Savvas opens up about the direction the product is heading — without giving specific details. The framing is ambitious: he wants to shift the paradigm of what real money entertainment means, not just iterate on the existing model. The inspiration is the intersection of prediction markets like Kalshi and Polymarket with social, synchronous entertainment. During COVID, people turned to online poker and cocktail-making together — the shared element transformed what could have been an isolated activity into a communal experience. Savvas believes the same principle can be applied to real-money gaming. The behavioural economics angle is compelling: loss aversion means that losing £10 requires winning back £20 to feel psychologically whole. But what if playing with another person changes that dynamic? If the shared experience reduces the multiplier from 2x to 1.5x or 1.2x, it fundamentally alters the product's relationship with the player. The pizza analogy captures it perfectly: nobody says they 'lost money' on a pizza — they shared one, and it was good. That's the emotional register MrQ is trying to reach: entertain the world, win or lose.
Savvas is building toward synchronous, shared entertainment — inspired by pandemic-era poker nights, Kalshi, and Polymarket. The insight is that players feel more engaged when they sense control and social connection. Can MrQ replicate that across real-money gaming beyond slots and live dealer?
Savvas cites the behavioural finance concept of loss aversion: losing £10 requires winning £20 back to feel psychological equilibrium, not just £10.
Savvas says the timing of MrQ's C-suite build was the single factor that determined whether the business survived the 40% tax shock. Even a few months slower would have left them without the leadership depth to absorb it. Building leadership is not operational prep — it's existential insurance.
The widely shared claim that we have a credit card's worth of plastic in our brains may be a massive overestimate. Researchers used nitrile gloves to measure microplastics — and nitrile gloves shed microplastic particles onto the measuring device. A second paper found the original tool used was unreliable, and that we may have far less plastic than reported.
RSD isn't just hurt feelings — it's a dopamine-deficient brain with a hyperactive amygdala and a frayed connection to the prefrontal cortex. Add a surge of norepinephrine and you get chest pain, sweating, and trembling that convinces your body something catastrophic is happening.
In Dan Ariely's door experiment, participants sacrificed the highest-reward door — repeatedly — just to avoid seeing other doors disappear. Even when researchers trained them to use the best door, they kept wasting clicks to maintain options. This is the bias that runs our lives: we'll take a worse outcome to preserve the feeling of optionality.
Dan Gilbert discovered that the brain has a 'psychological immune system' — it misremembers, reframes, and rationalizes to keep you satisfied with whatever you chose. The fear before commitment is all about potential regret. But after committing, your brain quietly starts justifying the choice — and the more irreversible the decision, the stronger the effect.
The psychological immune system can get you through the first few months of any commitment. But durable, long-term well-being requires self-concordance — choosing commitments that are genuinely aligned with your values and what you actually want. Without that alignment, the satisfaction fades fast.
Vision didn't just help animals find food — it ignited the Cambrian explosion of speciation. Half of the human cortex is devoted to visual processing, and that same visual hierarchy directly inspired the neural network architectures powering today's AI.
Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.
A pharmaceutical is not an amino acid sequence — it is the successful solution to manufacturing, purification, formulation, and consistency challenges. When clinical trials prove a drug works, they validate a specific product under specific processes, not every preparation that shares the same sequence.
Ask one question of any peptide advocate: what evidence would prove this claim wrong? If every disappointing result gets attributed to wrong dose, bad supplier, wrong timing, or improper stacking, the hypothesis is not falsifiable — and a non-falsifiable claim is not a scientific claim.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.